TABLE 4.
Incidence of adverse cardiovascular endpoints in 12 month follow‐up among AF and non‐AF populations of cardiomyopathy patients
| Variable | AF | Non‐AF | P‐value | OR [95% CI] | OR P‐value |
|---|---|---|---|---|---|
| Stroke/TIA | 26/820 (3.17%) | 21/1763 (1.19%) | <0.001 | 2.714 [1.518–4.853] | <0.001 |
| Death from any cause | 47/872 (5.39%) | 46/1840 (2.50%) | <0.001 | 2.222 [1.467–3.364] | <0.001 |
| Death from heart failure | 21/862 (2.44%) | 24/1832 (1.31%) | 0.033 | 1.881 [1.041–3.398] | 0.036 |
| Death from arrhythmia | 2/862 (0.23%) | 5/1832 (0.27%) | 1.000 | 0.850 [0.165–4.389] | 0.846 |
| Death from ischaemic stroke | 2/862 (0.23%) | 1/1832 (0.05%) | 0.242 | 4.241 [0.385–46.755] | 0.238 |
| Death from haemorrhagic stroke | 1/862 (0.12%) | 1/1832 (0.05%) | 0.538 | 2.126 [0.133–34.037] | 0.594 |
| Death from systemic haemorrhage | 1/862 (0.12%) | 0/1832 (0.00%) | 0.320 | 212910.950 [0.000–1] | 0.969 |
| Death from peripheral embolism | 0/862 (0.00%) | 0/1832 (0.00%) | NC | NC | NC |
AF, atrial fibrillation; CI, confidence interval; NC, not calculable; OR, odds ratio; TIA, transient ischaemic attack.